Post Holdings (POST) Earnings Analysis
Post Holdings (POST) has no confirmed upcoming earnings date. Last quarter (2026-02-05) it beat with EPS 2.13 USD vs 1.66 USD est (+28.3%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 13.98.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does POST next report earnings?
No confirmed upcoming earnings date is currently scheduled for POST. This page updates as the calendar is published.
POST earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-05 | 2.13 USD | 1.66 USD | +28.3% | Beat |
| 2025-11-20 | 2.09 USD | 1.87 USD | +11.8% | Beat |
| 2025-08-07 | 2.03 USD | 1.67 USD | +21.6% | Beat |
| 2025-02-06 | 1.73 USD | 1.49 USD | +16.1% | Beat |
| 2024-11-14 | 1.53 USD | 1.21 USD | +26.4% | Beat |
| 2024-08-01 | 1.54 USD | 1.25 USD | +23.2% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
POST valuation and analyst view
| Trailing P/E | 13.98 |
|---|---|
| Trailing EPS | 7.065 USD |
| Price / book | 1.36 |
| Dividend yield | 0.00% |
| Market cap | 4.15B |
| Analyst consensus | Buy (13 buy / 6 hold / 0 sell) |
| Avg price target | 112 USD |
Related research pages
Frequently asked questions
When is Post Holdings (POST)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for POST. This page updates as the calendar is published.
Did POST beat earnings last quarter?
In its 2026-02-05 report, POST posted EPS of 2.13 USD versus a 1.66 USD estimate — a beat of 28.3%.
What is POST's earnings track record?
Over the last 6 reported quarters with consensus data, POST beat estimates 6 times (100%).
What is POST's current P/E ratio and EPS?
POST trades at a trailing P/E of 13.98 on trailing EPS of 7.064718162839249 USD.
What do analysts rate POST?
Analyst consensus is "Buy" across 19 ratings (0 strong buy, 13 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 112 USD.